announces

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

August 15, 2025 08:00 ET  | Source: Catheter Precision, Inc. FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter…

10 months ago

Cyber A.I. Group Announces the Appointment of NASA Astronaut Charles J. Camarda as Strategic Innovation Advisor

Veteran Astronaut and Aerospace Innovator to Advance CyberAI’s Cutting-Edge AI and Cybersecurity Initiatives August 14, 2025 10:35 ET  | Source:…

10 months ago

UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025

Reports AUM of INR 12,081 Cr, up 31% (YoY); Total Income of INR 421.8 Cr, up 40% (YoY); and PAT…

10 months ago

Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor Common to Host

35 innovative, mission-driven organizations and changemakers selected from nearly 3,000 applicants across more than 120 countries RESTON, Va., Aug. 12,…

10 months ago

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R),…

10 months ago

Anteris Announces Results for the Second Quarter of 2025

MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR,…

10 months ago

JBO Vietnam Announces Exclusive 2026 FIFA World Cup Bonuses – Up to 16.8M VND

HANOI, Vietnam, Aug. 11, 2025 /PRNewswire/ -- With excitement growing for the 2026 FIFA World Cup, JBO Vietnam is proud to…

10 months ago

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to…

10 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am…

10 months ago

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…

10 months ago